Paracentesis is the standard treatment for refractory ascites in patients with cirrhosis, but it cannot prevent the recurrence of ascites. The placement of a transjugular intrahepatic portosystemic ...
Please provide your email address to receive an email when new articles are posted on . A new low-flow ascites pump significantly reduced paracentesis frequency in patients with a contraindication to ...
WASHINGTON, DC — For patients with acute-on-chronic liver failure (ACLF) undergoing modest-volume paracentesis for ascites, oral midodrine may be an alternative to intravenous albumin for preventing ...
Association between a validated symptom assessment tool and nurse clinical impression in patients with cancer admitted to a palliative care unit. This is an ASCO Meeting Abstract from the 2011 ASCO ...
THE problem of wasting ascites occurring in patients with cirrhosis of the liver is unsolved — both the pathogenesis of the ascites and its reliable cure. Recent observations have indicated the ...
ZURICH--(BUSINESS WIRE)--Versantis, a clinical-stage biotechnology company developing novel therapies for orphan liver and pediatric diseases, today announced that positive Phase 1b clinical data from ...
BioVie’s stock has moved up considerably over the past 9 months in light of promising Alzheimer’s data. BioVie Day and full Phase 2 Parkinson’s trial results are scheduled for this month. BioVie has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback